Johnson & Johnson vs Mastercard: Founders, CEOs and History
Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato. Mastercard was founded in 1966 by Karl Hinke and is led by Michael Miebach.
Company facts
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Mastercard
- Founded
- 1966
- Headquarters
- Purchase, New York, United States
- Current CEO
- Michael Miebach
- Employees
- 39,800
Founders
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
Mastercard
Karl Hinke
Karl Hinke was an executive at Marine Midland Bank in New York who helped organize the Interbank Card Association in 1966.
CEOs and their tenures
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Mastercard
- Robert W. Selander1997–2010
President and CEO
Selander turned a bank-owned association into an independent public company, completing the 2002 Europay merger and the 2006 NYSE IPO.
Source - Ajay Banga2010–2020
CEO
Banga oversaw a decade of rapid growth, pushed tokenization and digital wallets, and bought Vocalink to enter real-time account-to-account payments. He later became President of the World Bank in 2023.
Source - Michael Miebach2021–present
CEO
Miebach has expanded value-added services to about 41% of net revenue and added Recorded Future and BVNK, extending Mastercard into threat intelligence and stablecoin infrastructure.
Source
Timeline: Johnson & Johnson and Mastercard side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1966Mastercard
Interbank Card Association Takes Shape
A group of U.S. Banks formed the Interbank Card Association to make card acceptance work across institutions rather than inside isolated bank programs.
1968Mastercard
Master Charge Brand Adopted
The association adopted the Master Charge name and interlocking-circle design to give member banks a stronger shared identity. A common brand made the network easier for merchants and consumers to recognize as acceptance expanded beyond local bank programs.
1979Mastercard
Master Charge Becomes MasterCard
The network changed its name from Master Charge to MasterCard as it became more international. The rebrand simplified recognition and helped the company present itself as a global acceptance network rather than a domestic bank-card association.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
2002Mastercard
Europay Merger and Corporate Conversion
MasterCard merged with Europay International and converted from a membership association into a private share corporation. That structure prepared the company for public-market ownership and a more independent investment agenda.
2006Mastercard
Initial Public Offering on the NYSE
MasterCard priced its initial public offering at $39 per share and listed on the New York Stock Exchange under the symbol MA.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2017Mastercard
Vocalink Expands Real-Time Payments
Mastercard completed its Vocalink acquisition after announcing a deal for 92.4 percent of the U.K. Payments infrastructure company for about $920 million.
2020Mastercard
Finicity Strengthens Open Banking
Mastercard completed the acquisition of Finicity, a North American financial data and open banking platform. The deal added consumer-permissioned data connectivity for lending, account verification, personal finance, and account-based payment use cases.
2021Mastercard
Michael Miebach Becomes CEO
Michael Miebach became chief executive officer on January 1, 2021 after serving as chief product officer and president.
2021Mastercard
Nets Account-to-Account Business Closes
Mastercard completed the acquisition of the majority of Nets' Corporate Services business, adding clearing and settlement instant payment infrastructure, bill payment, and e-invoicing capabilities.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2024Mastercard
Recorded Future Adds Threat Intelligence
Mastercard completed the acquisition of Recorded Future, adding AI-enabled threat intelligence to its cybersecurity, identity, and real-time fraud scoring services.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2025Mastercard
$32.8B FY2025 Net Revenue
Mastercard reported $32.791 billion in FY2025 net revenue and $14.968 billion in net income.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
2026Mastercard
BVNK Adds Stablecoin Infrastructure
Mastercard closed its acquisition of stablecoin infrastructure firm BVNK on August 3, 2026, for up to $1.8 billion including contingent payments. The deal extends the company's network to on-chain payments alongside cards and bank transfers.
Acquisitions
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Mastercard
- BVNK2026$1.8B
- Recorded Future2024$2.6B
- Dynamic Yield2022Undisclosed
- Nets account-to-account payment business2021$3.2B
- Ekata2021$850M
- Aiia2021Undisclosed
Questions about Johnson & Johnson vs Mastercard
Who is the CEO of Johnson & Johnson and Mastercard Incorporated?
Johnson & Johnson is led by Joaquin Duato and Mastercard Incorporated is led by Michael Miebach. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Johnson & Johnson founded vs Mastercard Incorporated?
Johnson & Johnson was founded in 1886 — 80 years before Mastercard Incorporated, which was founded in 1966. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Mastercard Incorporated.
How many employees does Johnson & Johnson have compared to Mastercard Incorporated?
Johnson & Johnson employs approximately 140,800 people, while Mastercard Incorporated employs approximately 39,800. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Mastercard Incorporated's 39,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Johnson & Johnson and Mastercard Incorporated headquartered?
Both Johnson & Johnson and Mastercard Incorporated are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Johnson & Johnson and Mastercard Incorporated?
Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson. Mastercard Incorporated was founded by Karl Hinke.
Which company has a longer operating history — Johnson & Johnson or Mastercard Incorporated?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Mastercard Incorporated has been in operation for around 60 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Johnson & Johnson vs Mastercard overview